Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects
Status:
Terminated
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
To assess comparative radiographic efficacy, clinical efficacy and safety of etanercept (ETN)
+ methotrexate (MTX) with usual disease-modifying anti-rheumatic drug (DMARD) treatment in
subjects with moderate RA who were treated with MTX monotherapy, but continue to have
moderate disease activity.